Exporter

EN
FR
Amoxicillin + clavulanic acid
Statut de médicament essentiel
Description générale
Amoxicillin is an extended spectrum penicillin antibiotic. Clavulanic acid is a beta-lactamase inhibitor.
INN
Amoxicillin + clavulanic acid
Codes ATC
J01CR02
Type de médicament
Chemical agent
Groupes d'antibiotiques
ACCESS
Historique des statuts LME
Ajouté pour la première fois en 1997 (TRS 882) pour Bacterial infection of unspecified site
Ajouté en 2017 (TRS 1006) pour Acute otitis media
Ajouté en 2017 (TRS 1006) pour Infectious cystitis
Ajouté en 2017 (TRS 1006) pour Acute sinusitis
Ajouté en 2017 (TRS 1006) pour Osteomyelitis or osteitis
Ajouté en 2017 (TRS 1006) pour Neutropenia
Ajouté en 2017 (TRS 1006) pour Peritoneal abscess
Ajouté en 2017 (TRS 1006) pour Peritonitis
Ajouté en 2017 (TRS 1006) pour Bacterial pneumonia
Ajouté en 2017 (TRS 1006) pour Other specified pneumonia
Wikipédia
Amoxicillin + clavulanic acid
DrugBank
Amoxicillin ,
Clavulanic acid (Clavulanate)
Recommandations
Section
Access group antibiotics
  • Parenteral > General injections > IV: 500 mg (as sodium salt) + 100 mg (as potassium salt) powder for injection; 1000 mg (as sodium salt) + 200 mg (as potassium salt) powder for injection
  • Oral > Solid > tablet: 500 mg (as trihydrate) + 125 mg (as potassium salt)
  • Oral > Liquid: 125 mg (as trihydrate) + 31.25 mg (as potassium salt) / 5 mL powder for oral liquid; 250 mg (as trihydrate) + 62.5 mg (as potassium salt) / 5 mL powder for oral liquid
  • Oral > Solid > dispersible tablet: 200 mg (as trihydrate) + 28.5 mg (as potassium salt); 250 mg (as trihydrate) + 62.5 mg (as potassium salt)
  • Oral > Solid > tablet: 500 mg (as trihydrate) + 125 mg (as potassium salt); 875 mg (as trihydrate) + 125 mg (as potassium salt)
Indications
Premier choix
Peritonitis (mild-moderate) Bacterial pneumonia (Community-acquired pneumonia - severe) [children] Other specified pneumonia (Hospital-acquired pneumonia) Peritoneal abscess (mild-moderate) Neutropenia (low-risk) Infectious cystitis Acute sinusitis Bacterial cellulitis, erysipelas or lymphangitis Chronic obstructive pulmonary disease with acute exacerbation
Second choix
Other specified prophylactic measures Bacterial pneumonia (Community-acquired pneumonia - mild to moderate) Acute otitis media Osteomyelitis or osteitis Bacterial infection of joint co-prescrite avec clarithromycin Bacterial pneumonia (Community-acquired pneumonia - severe)
Autres indications
Bacterial infection of unspecified site
Section
Antituberculosis medicines
  • Oral > Liquid: 250 mg (as trihydrate) + 62.5 mg (as potassium salt) / 5 mL powder for oral liquid
  • Oral > Solid > tablet: 500 mg (as trihydrate) + 125 mg (as potassium salt)
Indications
Multi-drug resistant Mycobacterium tuberculosis